OKYO logo

OKYO Pharma Limited (OKYO) Financials

Balance sheets

31 Mar 202330 Sept 202231 Mar 202230 Sept 202131 Mar 202130 Sept 202031 Mar 2020

Total Assets

$5.2 M(+193.3%)$1.8 M(-58.7%)$4.3 M(-23.3%)$5.6 M(-20.9%)$7.1 M(-5.6%)$7.5 M(+1157.6%)$597.4 K

Current Assets

$5.2 M(+193.8%)$1.8 M(-58.8%)$4.3 M(-22.2%)$5.5 M(-21.0%)$7.0 M(-6.6%)$7.5 M(+1220.4%)$566.7 K

Non Current Assets

$7200.0(+28.6%)$5600.0(+7.7%)$5200.0(-93.9%)$85.8 K(-18.0%)$104.6 K(+245.2%)$30.3 K(-1.3%)$30.7 K

Total Liabilities

$7.3 M(+242.3%)$2.1 M(+56.7%)$1.4 M(+103.7%)$664.4 K(-62.5%)$1.8 M(+301.9%)$440.9 K(-40.2%)$737.2 K

Current Liabilities

$7.3 M(+242.3%)$2.1 M(+56.7%)$1.4 M(+119.2%)$617.3 K(-63.8%)$1.7 M(+309.3%)$417.1 K(-41.3%)$710.7 K

Long Term Liabilities

$0.0(0%)$0.0(0%)$0.0(-100.0%)$47.1 K(-27.1%)$64.6 K(+171.4%)$23.8 K(-10.2%)$26.5 K

Shareholders Equity

-$2.1 M(-493.8%)-$345.8 K(-111.7%)$2.9 M(-40.4%)$4.9 M(-7.1%)$5.3 M(-24.8%)$7.1 M(+5158.7%)-$139.8 K

Book Value

-$2.1 M(-493.8%)-$345.8 K(-111.7%)$2.9 M(-40.4%)$4.9 M(-7.1%)$5.3 M(-24.8%)$7.1 M(+5158.7%)-$139.8 K

Working Capital

-$2.1 M(-486.4%)-$351.4 K(-111.9%)$2.9 M(-40.0%)$4.9 M(-7.1%)$5.3 M(-25.3%)$7.1 M(+5006.6%)-$144.0 K

Cash And Cash Equivalents

$4.0 M(+471.7%)$707.6 K(-73.8%)$2.7 M(-47.8%)$5.2 M(-25.0%)$6.9 M(-7.0%)$7.4 M(+3053.9%)$235.0 K

Accounts Payable

$2.4 M(+56.8%)$1.5 M(+105.3%)$741.8 K(+244.1%)$215.6 K(+2.2%)$211.0 K(-36.4%)$331.6 K(-44.1%)$593.7 K

Accounts Receivable

-------

Short Term Debt

$2.2 M(+100.0%)$0.0-$34.4 K(+0.9%)$34.1 K(+568.6%)$5100.0(0%)$5100.0

Long Term Debt

-$0.0-$47.1 K(-27.1%)$64.6 K(+171.4%)$23.8 K(-10.2%)$26.5 K

Total Debt

$2.2 M(+100.0%)$0.0(0%)$0.0(-100.0%)$81.5 K(-17.4%)$98.7 K(+241.5%)$28.9 K(-8.5%)$31.6 K

Debt To Equity

-1.1(-100.0%)0.0(0%)0.0(-100.0%)0.0(0%)0.0(+100.0%)0.0(+100.0%)-0.2

Current Ratio

0.7(-13.3%)0.8(-73.8%)3.2(-64.6%)8.9(+118.8%)4.1(-77.2%)17.9(+2142.5%)0.8

Quick Ratio

-------

Inventory

-------

Retained Earnings

-$125.7 M(-38.3%)-$90.9 M(+19.1%)-$112.4 M(-12.5%)-$100.0 M(+5.7%)-$106.0 M(-17.1%)-$90.6 M(-5.5%)-$85.9 M

PB Ratio

-42.0(+74.6%)-165.6-----

Income statements

Cashflow statements

31 Mar 202330 Sept 202231 Mar 202230 Sept 202131 Mar 202130 Sept 202031 Mar 2020

Cash From Operations

-------

TTM CFO

-------

Cash From Investing

-------

TTM CFI

-------

Cash From Financing

-------

TTM CFF

-------

Free Cash Flow

-------

TTM FCF

-------

CAPEX

-------

TTM CAPEX

-------

Dividends Paid

-------

TTM Dividends Paid

-------

TTM Dividend Per Share

-------

TTM Dividend Yield

-------

Payout Ratio

-------